Finadyne, 50 mg/ml, solution for injection
Finadyne, 50 mg/ml, solution for injection
Authorised
- Flunixin meglumine
Product identification
Medicine name:
Finadyne 50 mg/ml Oplossing voor injectie
Finadyne 50 mg/ml Solution injectable
Finadyne 50 mg/ml Injektionslösung
Finadyne, 50 mg/ml, solution for injection
Active substance:
- Flunixin meglumine
Target species:
-
Cattle
-
Horse
-
Pig
Route of administration:
-
Intravenous use
-
Intramuscular use
-
Intramuscular use
-
Intramuscular use
Product details
Active substance and strength:
-
Flunixin meglumine83.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intravenous use
-
Cattle
-
Meat and offal4day
-
Milk24hour
-
-
Horse
-
Meat and offal5day
-
Milkno withdrawal periodLeche: Su uso no est� autorizado en animales cuya leche se utiliza para el consumo humano.
-
-
-
Intramuscular use
-
Pig
-
Meat and offal24day
-
-
-
Intramuscular use
-
Cattle
-
Meat and offal31day
-
-
-
Intramuscular use
-
Cattle
-
Milk36hour
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM01AG90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- 1 Cardboard box with 10 x 50 ml vial
- 1 Cardboard box with 1 x 250 ml vial
- 1 Cardboard box with 1 x 100 ml vial
- 1 Cardboard box with 1 x 50 ml vial
- 1 Cardboard box with 6 x 50 ml vial
- 1 Cardboard box with 6 x 250 ml vial
- 1 Cardboard box with 10 x 100 ml vial
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Trirx Segre
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V122507
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Combined File of all Documents
English (PDF)
Download Published on: 5/06/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.
